11min chapter

Diabetes Core Update cover image

Diabetes Core Update – February 2024

Diabetes Core Update

CHAPTER

Low-Dose Anti-Thimocyte Globulin for Type One Diabetes

This chapter discusses a study on the use of low-dose anti-thimocyte globulin as a treatment for stage two type one diabetes. They explore the background of the study, the pilot study that led to larger confirmatory results, and the implementation of anti-thimocyte globulin as a viable treatment option.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode